Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease.

de Borst MH, Vervloet MG, ter Wee PM, Navis G.

J Am Soc Nephrol. 2011 Sep;22(9):1603-9. doi: 10.1681/ASN.2010121251. Epub 2011 Aug 18.

2.

Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition.

de Seigneux S, Martin PY.

Pharmacol Res. 2016 Apr;106:87-91. doi: 10.1016/j.phrs.2016.02.015. Epub 2016 Feb 18. Review.

PMID:
26900884
3.

[Pathologies of calcium-phosphate homeostasis].

Karczmarewicz E, Czekuć-Kryskiewicz E, Lorenc RS.

Postepy Biochem. 2012;58(4):474-7. Review. Polish.

PMID:
23662440
4.

[FGF-23 and Klotho protein - new markers in chronic kidney disease?].

Mituła I, Gołembiewska E, Ciechanowski K, Siuda A.

Pol Merkur Lekarski. 2013 Apr;34(202):235-8. Review. Polish.

PMID:
23745333
5.

Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.

Lim K, Lu TS, Molostvov G, Lee C, Lam FT, Zehnder D, Hsiao LL.

Circulation. 2012 May 8;125(18):2243-55. doi: 10.1161/CIRCULATIONAHA.111.053405. Epub 2012 Apr 5.

6.

Klotho and chronic kidney disease.

Hu MC, Kuro-o M, Moe OW.

Contrib Nephrol. 2013;180:47-63. doi: 10.1159/000346778. Epub 2013 May 3. Review.

7.

Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.

Prié D, Friedlander G.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1717-22. doi: 10.2215/CJN.02680310. Epub 2010 Aug 26. Review.

8.

Role of Klotho in aging, phosphate metabolism, and CKD.

John GB, Cheng CY, Kuro-o M.

Am J Kidney Dis. 2011 Jul;58(1):127-34. doi: 10.1053/j.ajkd.2010.12.027. Epub 2011 Apr 15. Review.

9.

New insights into the FGF23-Klotho axis.

Olauson H, Vervloet MG, Cozzolino M, Massy ZA, Ureña Torres P, Larsson TE.

Semin Nephrol. 2014 Nov;34(6):586-97. doi: 10.1016/j.semnephrol.2014.09.005. Review.

PMID:
25498378
10.

Can vitamin D slow down the progression of chronic kidney disease?

Shroff R, Wan M, Rees L.

Pediatr Nephrol. 2012 Dec;27(12):2167-73. doi: 10.1007/s00467-011-2071-y. Epub 2011 Dec 10. Review.

PMID:
22160397
11.

Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.

Humalda JK, Lambers Heerspink HJ, Kwakernaak AJ, Slagman MC, Waanders F, Vervloet MG, Ter Wee PM, Navis G, de Borst MH; NIGRAM Consortium..

Am J Kidney Dis. 2015 Feb;65(2):259-66. doi: 10.1053/j.ajkd.2014.07.022. Epub 2014 Sep 30.

PMID:
25278093
12.

Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.

Shroff R, Aitkenhead H, Costa N, Trivelli A, Litwin M, Picca S, Anarat A, Sallay P, Ozaltin F, Zurowska A, Jankauskiene A, Montini G, Charbit M, Schaefer F, Wühl E; ESCAPE Trial Group..

J Am Soc Nephrol. 2016 Jan;27(1):314-22. doi: 10.1681/ASN.2014090947. Epub 2015 Jun 11.

13.

Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.

Koizumi M, Komaba H, Fukagawa M.

Contrib Nephrol. 2013;180:110-23. doi: 10.1159/000346791. Epub 2013 May 3. Review.

PMID:
23652554
14.

Klotho/FGF23 Axis in CKD.

Tsuchiya K, Nagano N, Nitta K.

Contrib Nephrol. 2015;185:56-65. doi: 10.1159/000380970. Epub 2015 May 19. Review.

PMID:
26023015
15.

Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease.

de Brito Galvao JF, Nagode LA, Schenck PA, Chew DJ.

J Vet Emerg Crit Care (San Antonio). 2013 Mar-Apr;23(2):134-62. doi: 10.1111/vec.12036. Review.

16.

Fibroblast growth factor 23--structure, function and role in kidney diseases.

Kocełak P, Olszanecka-Glinianowicz M, Chudek J.

Adv Clin Exp Med. 2012 May-Jun;21(3):391-401. Review.

17.

Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease.

Sawires HK, Essam RM, Morgan MF, Mahmoud RA.

Nephron. 2015;129(4):293-9. doi: 10.1159/000377633. Epub 2015 Mar 10.

18.

Beyond mineral metabolism, is there an interplay between FGF23 and vitamin D in innate immunity?

Bacchetta J, Salusky IB, Hewison M.

Pediatr Nephrol. 2013 Apr;28(4):577-82. doi: 10.1007/s00467-012-2336-0. Epub 2012 Nov 2. Review.

19.

FGF23, klotho and vitamin D interactions: What have we learned from in vivo mouse genetics studies?

Razzaque MS.

Adv Exp Med Biol. 2012;728:84-91. doi: 10.1007/978-1-4614-0887-1_5. Review.

PMID:
22396163
20.

Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.

de Cavanagh EM, Inserra F, Ferder L.

Am J Physiol Heart Circ Physiol. 2015 Jul 1;309(1):H15-44. doi: 10.1152/ajpheart.00459.2014. Epub 2015 May 1. Review.

Supplemental Content

Support Center